CoNexus Care therapy has been used by its innovative treating cancer researchers/treating physicians to favorably change late stage cancer patients' lives for over thirty years!

CoNexus Care has been shown to shrink, reduce, and even neutralize primary and/or metastatic tumor masses for over thirty-five years, even those deemed untreatable by many highly reputable cancer centers.

This is vitally important when you know the majority conventional cancer treatments fail to stop aggressive cancerous cells from eventually spreading to other parts of the body or its organs (metastasis). Why, because aggressive tumor cells almost always extend beyond their perceived margins (microscopic spread). However, highly skilled ICCA physicians understood the consequences of metastasis as far back as 1989, and spent years perfecting CoNexus Care, offers an individualized, clinically based therapies to instigate favorable expedite biological effects that lead to tumor mass shrinkage, reduction, and/or cancer cell neutralization.

CoNexus Care was developed over thirty years ago to harness, strengthen, and enhance a patient's overall immune system in order to fight cancer for an extended period of time, with CoNexus Care providing many measurable advantages over conventional cancer immunotherapies which rely on chemotherapy, radiation or surgery or some limited combination therein.

CoNexus Care is quite simply, a therapeutic procedure that uses the patient's own tumor mass to help create anticancer vaccine unique to the patient. Treatments are administered over a two to three week period, take less than 45 minutes to administer per treatment, minimally invasive, and cause few, if any, side-effects.

ICCA's highly skilled physicians and surgeons administer clinically proven treatments shown to destroy cancerous tumor cells without compromising the patient's quality of life. All of which have undergone rigorous clinical trials and studies in many global medical venues such as Germany, United States, Canada, Cuba, United Kingdom, South Korea, China and the National Cancer Institute in Mexico.

If you or a loved one is facing a treatment decision, losing hope, or looking for alternative treatment options, please take the time to review our website, then call us with any questions.

We're here to help you understand the unique benefits of CoNexus Care!

CoNexus Care involves several non-toxic antigen vaccines injected directly into the tumor under CT scan guidance.

Chemo drugs circulate through the entire body eventually damaging both healthy and cancerous tumor cells.

The injected antigen vaccine stays within the tumor, never circulating through the body.

CoNexus Immunotherapy Cancer Care is designed to serve three vitally important functions:

• Greatly reduce or eliminate late stage or inoperable tumors without causing unnecessary damage to surrounding tissues - even when the tumor is classified inoperable by many well-intended Comprehensive Cancer Centers.
• Hinder the spreading of cancer cells (metastasis) by administering similar tumor antigens throughout the body, designed specifically to enhance cancer cell death.
• Enhance Immune Cell Response by administering a dendritic cancer vaccine designed specifically to better identify deceiving cancer cells and help destroy, prevent or even reverse progressive tumor growth.

CoNexus Care involves administration of a uniquely individualized precision tumor-targeted cancer therapy in concert with other neoadjuvant science-based immunotherapeutic s (i.e. dendritic cells, autologous cellular vaccine, autologous adaptive immunotherapy, etc.).

There are three significant considerations for patients when discussing potential cancer therapy regardless of the cancer center or their oncologists:

• How long is the treatment going to be?
• Is the treatment going to affect my quality of life?
• What are the chances that the cancer will return?

---

---